NeoDiagnostix is committed to pioneering the field of personalized medicine through cancer genomics. By combining the most advanced diagnostics with therapeutics, we enable clinicians to determine the best course of treatment for the patient. NeoDiagnostix is merging the most advanced molecular DNA technologies with a substantial portfolio of proprietary biomarkers that have been closely linked to oncologic disease. We are committed to providing clinicians with a patient specific molecular profile that will provide crucial insights into cancer leading to improved or individualized patient care.

• 肿瘤基因组